RMC-7977, a highly selective inhibitor of the active RAS-GTP to treat pancreatic cancer
Saved in:
Main Authors: | Ying-Qi Song (Author), Qingjun Li (Author), Chunquan Sheng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of literature on RMC and applications to Tanzania
by: Karline Wilson-Mitchell, et al.
Published: (2018) -
Probing mutation-induced conformational transformation of the GTP/M-RAS complex through Gaussian accelerated molecular dynamics simulations
by: Huayin Bao, et al.
Published: (2023) -
Hyperinsulinemia contributes to impaired-glucose-tolerance-induced renal injury mir-7977/SIRT3 signaling
by: Zhongai Gao, et al.
Published: (2020) -
The psychometric properties of the respectful maternity care (RMC) for an Iranian population
by: Khadije Hajizadeh, et al.
Published: (2020) -
Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis?
by: Anderson Michelle A, et al.
Published: (2008)